NIFTY 50
22,904.45 (-1.49%)
NIFTY IT
33,511.40 (-3.58%)
NIFTY AUTO
20,593.15 (-2.70%)
NIFTY FINANCIAL SERVICES
24,774.30 (0.20%)
NIFTY BANK
51,502.70 (-0.18%)
NIFTY REALTY
823.05 (-3.60%)
NIFTY ENERGY
32,308.90 (-3.73%)
NIFTY METAL
8,414.45 (-6.56%)
NIFTY FMCG
53,830.70 (0.04%)
NIFTY HEALTH CARE
13,426.80 (-3.05%)
NIFTY PHARMA
20,560.00 (-4.03%)
NIFTY MEDIA
20,560.00 (-4.03%)
Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

   Quarterly Results
Change Company Name
Dr Reddys Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 500124 ISIN Demat INE089A01031 Book Value 322.46 NSE Symbol DRREDDY Dividend Yield (%) 0.69 Market Cap ( Cr.) 96,066.67 P/E 18.53 EPS 62.12 Face Value 1

Particulars (₹ Cr)Dec 2024Sep 2024Jun 2024Mar 2024
Gross Sales/Income from operations 4997.86678.85823.95081.8
Less: Excise duty 0.000.000.000.00
Net Sales/Income from operations 4,997.806,678.805,823.905,081.80
Other Operating Income 17.2017.5017.3023.00
Total Income from operations (net) 5,015.006,696.305,841.205,104.80
Total Expenses 4,087.704,234.704,138.003,972.40
Cost of Sales 1,483.101,497.801,525.301,402.00
Employee Cost 794.40840.10855.90779.50
Depreciation, amortization and depletion expense 265.10260.00249.80246.20
Provisions & Write Offs 0.000.000.0026.00
Administrative and Selling Expenses 0.000.000.000.00
Other Expenses 1,545.101,636.801,507.001,518.70
Pre Operation Expenses Capitalised 0.000.000.000.00
Profit from operations before other income, finance costs and exceptional items 927.302,461.601,703.201,132.40
Other Income 235.40207.60217.80212.70
Profit from ordinary activities before finance costs and exceptional items 1,162.702,669.201,921.001,345.10
Finance Costs 43.3028.407.105.90
Profit from ordinary activities after finance costs but before exceptional items 1,119.402,640.801,913.901,339.20
Exceptional Items 0.000.000.000.00
Other Adjustments Before Tax 0.000.000.000.00
Profit from ordinary activities before tax 1,119.402,640.801,913.901,339.20
Total Tax 270.00758.70496.70304.40
Net profit from Ordinary Activities After Tax 849.401,882.101,417.201,034.80
Profit / (Loss) from Discontinued Operations 0.000.000.000.00
Net profit from Ordinary Activities/Discontinued Operations After Tax 849.401,882.101,417.201,034.80
Extraordinary items 0.000.000.000.00
Other Adjustments After Tax 0.000.000.000.00
Net Profit after tax for the Period 849.401,882.101,417.201,034.80
Other Comprehensive Income -58.30-6.604.10-12.00
Total Comprehensive Income 791.101,875.501,421.301,022.80
Equity 83.4083.4083.4083.40
Reserve & Surplus 0.000.000.000.00
Face Value 1.005.005.005.00
EPS:     
EPS before Exceptional/Extraordinary items-Basic 10.20113.0085.1062.14
EPS before Exceptional/Extraordinary items-Diluted 10.18112.8084.9762.04
EPS after Exceptional/Extraordinary items-Basic 10.20113.0085.1062.14
EPS after Exceptional/Extraordinary items-Diluted 10.18112.8084.9762.04
Book Value (Unit Curr.) 0.000.000.000.00
Dividend Per Share(Rs.) 0.000.000.000.00
Dividend (%) 0.000.000.000.00
No. of Employees 0.000.000.000.00
Debt Equity Ratio 0.000.000.000.00
Debt Service Coverage Ratio 0.000.000.000.00
Interest Service Coverage Ratio 0.000.000.000.00
Debenture Redemption Reserve (Rs cr) 0.000.000.000.00
Paid up Debt Capital (Rs cr) 0.000.000.000.00
  • Copyright © 2024   INVES 21
  • Designed, developed and Content Provide by CMOTS Infotech (ISO 9001:2015 certified)